# Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

> **NCT01355133** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 40 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **BIOLOGICAL:** Transurethral intrasphincteric autologous myoblast implantation

## Key facts

- **NCT ID:** NCT01355133
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2011-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355133, "Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01355133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*